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Transcription factors (TFs) are a family of DNA-binding proteins whose gene regulatory capa-
bilities are of vital importance in defining the molecular state of a cell. Despite their biological
significance, our understanding of TF behavior and function is still limited. This is because
we have so far mostly relied on gene expression data to approximate TF protein levels given
that the latter information has been notoriously difficult to obtain due to the relatively low ex-
pression levels of many TFs. However, significant advances in mass spectrometry technologies
combined with the development of sensitive methodologies aimed at detecting TFs are now
allowing a transition from a predominantly qualitative to a quantitative protein landscape. Such
a paradigm shift is expected to unravel dynamic aspects of TF function, potentially linking TF
copy number fluctuations in cells with specific regulatory functions. This in turn may pro-
vide novel insights into the regulatory mechanisms underlying a wide range of fundamental
and disease-related biological processes. In this review, we will present the latest advances
in mass spectrometry-based TF proteomics and describe novel strategies tailored around the
quantification of this important family of DNA-binding proteins.
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1 Introduction (transcription factors and
their regulatory properties)
Understanding how the expression of genes is regulated
is of fundamental importance in biology. This is because
the vast majority of biological processes, from development
to homeostasis maintenance, from cell cycle to cell differ-
entiation, are tuned by differential gene expression. Due
to significant advances in genomic, proteomic, and other
molecular technologies, we are achieving an increasingly
detailed view of the gene regulatory networks (GRNs) that
control gene expression [1,2]. GRNs capture the physical and
functional interactions between DNA-binding regulatory
proteins, transcription factors (TFs), and regulatory elements
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associated with their target genes (i.e. promoters, enhancers).
The key function of these GRNs is to coordinate the estab-
lishment of distinct molecular states both in space and time.
However, most GRNs are still vastly incomplete and their
components far from being completely characterized. This
data paucity significantly hampers our ability to model these
networks and infer how the regulation of specific genes is
orchestrated. To attain such a detailed level of understanding,
novel approaches will need to be developed and data across
a wide range of methods will need to be integrated.
2 Inferring transcription factor regulatory
properties from their abundance in cells
Although qualitative information regarding the regulatory be-
havior of TFs is widely available in the literature [3–5], reliable
TF protein measurements are much scarcer. This disparity
can in part be explained by the fact that TFs tend not to
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be highly abundant in cells [6–10], which makes quantitative
analyses a substantial challenge considering the complexity of
eukaryotic proteomes and the current state of protein analyt-
ical technologies. This is despite the importance of retrieving
accurate, quantitative protein level data to generate in silico
models of specific regulatory mechanisms. Indeed, the copy
number of TFs is a key aspect of gene regulation given that
the ability of a TF to bind to DNA and thus to exert its regula-
tory function is in part determined by its nuclear abundance
[11–13]. Neglecting to incorporate such quantitative data in
gene regulatory models or to simply infer it using gene ex-
pression data introduces therefore biases [14–17] and leads to
incomplete understanding of regulatory mechanisms. Thus,
TF levels need to be experimentally measured to determine
howmuch of a binding site will be occupied by a TF to assess
or model its regulatory input.
Moreover, interest in obtaining quantitative data onTFs de-
rives not only from a fundamental interest in understanding
how they regulate gene expression, but also from a biomedi-
cal perspective. This is because aberrations in TF levels and
function are responsible for a variety of disorders e.g. [18,19].
It is therefore not surprising that there has always been a
great interest in this particular family of proteins as potential
pharmaceutical targets to treat a variety of diseases, includ-
ing cancer [20–23], even though TFs are admittedly rather
difficult to target [24].
Various techniques are available for the quantification of
proteins nowadays, the majority of which rely on the use of
antibodies (e.g. ELISA, proteinmicroarrays [25]). Quantitative
immunoassays are widely used because of their accuracy and
the fact that they can be implemented even in a basic labora-
tory setting due to their low cost and simplicity. Nevertheless,
these techniques suffer from a certain number of drawbacks,
non-linearity in quantitation, and formation of unspecific re-
actions to name a few [26].Moreover, quantitation of different
proteins normally necessitates separate experiments, not to
mention that only a limited number of TF-specific antibodies
are commercially available, limiting thereby the applicability
of these methodologies to small scale studies of several TFs
at the time. In this regard, there is a strong need for robust
methodologies that could bypass such limitations, possibly
pushing the current limits in terms of sensitivity and speci-
ficity even further. In this review, we will describe the tools
and methods that are currently available to study TFs from
a quantitative standpoint utilizing mass spectrometry, giv-
ing much attention to strategies aimed at enriching these
molecules from their complex native environment to ease
their detectability. We will thereby mostly focus on studies
introducing the approaches rather than on those applying
them. As such, we will at first enumerate the most adopted
techniques to detect and subsequently quantify DNA-binding
proteins, and describe the most recent improvements in the
isolation and enrichment of TFs. Subsequently, the differ-
ent quantification approaches will be described in greater
detail along with practical examples from the recent liter-
ature. Here, we will introduce the concepts of relative as
well as absolute quantification, and describe in which cir-
cumstances the use of one over the other would be more
appropriate. A separate section will be devoted to targeted
mass spectrometry-based approaches, as the recent resurrec-
tion of such techniques has not only proven beneficial in the
detection of medium-to-low abundant molecules due to their
inherent high sensitivity and specificity, but also because tar-
geted approaches are amenable to throughput increase and
automation. Note that the concept and characteristics of each
approach have been summarized in Table 1.
3 Mass spectrometry-based proteomics
as a tool for transcription factor
analysis
Until recently, mass spectrometry-based methodologies sim-
ply lacked the necessary sensitivity to be used for the identifi-
cation of low abundant proteins. Noticeable improvements in
mass spectrometer detection limits have enhanced our quan-
titative analysis capacities of proteins that are expressed at
medium to low levels in cells, such as TFs. In essence, one
can segregate MS-based quantification methodologies into
twomajor classes: those requiring stable isotope labeling and
those that do not necessitate labeling, so called “label-free”.
(1) Label-free approaches: such methodologies are cost effi-
cient, amicable to up-scaling and can be based onMS2 or
MS1 level data [27,28]. Spectral counting label-free quan-
tification uses the number of acquired MS2 spectra per
protein as a proxy for protein abundance. Although easy
to implement, spectra count based quantification is to be
considered as semi-quantitative since it provides limited
accuracy and precision. Better quantification properties
in terms of dynamic range, accuracy and precision, can
in this regard be achieved by using MS1-based label-free
quantification. Here, dedicated software is used to extract
peptide ion intensities that are subsequently summarized
to protein level abundance values. Recently, considerable
effort has been devoted to overcome such limitations (for
an evaluation of label-free quantification methods, we re-
fer to [29]), aiming to combine the benefits of label-free
analyses with the sensitivity of targeted MS approaches.
(2) Labeling approaches: the majority of these techniques
employ metabolic (SILAC or Stable Isotope Labeling of
Amino Acids in Cell Culture) or variations of chemical
stable isotope labeling to introduce a predictable mass
shift between peptides from two or more experimen-
tal conditions (these approaches have been extensively
reviewed in [30, 31]). Stable isotope-labeling quantifica-
tion entails the use of “heavy”-labeled molecules, such
as AQUA [32], in which selected chemically synthesized
isotope-labeled peptides are carefully quantified and used
as standards. “Heavy”-to-“light” peptide ratios define the
amount of the endogenous protein present within the bi-
ological sample. Issueswith the cost of these peptides and
with its storage have pushed for an amelioration of the
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technique, in which concatenated peptides (QconCAT)
[33] are utilized. One of the criticisms though regarding
QconCAT constructs revolves around the digestion of its
tryptic peptides, which does not necessarily mirror the
digestion of endogenous proteins. For this particular rea-
son,many laboratories have oriented theirmethodologies
towards the expression of full-length proteins, expressed
either in vivo (e.g. Absolute SILAC) [34] or in vitro (PSAQ)
[35]), which are spiked at some stage of sample prepara-
tion within the complex mixture. The main advantage is
that all tryptic peptides generated from the protein, except
the C-terminal one, can be readily monitored. This appli-
cation tries to overcome issues related to peptide detec-
tion, because a large fraction of protein-specific peptides
may not be identifiable due to sample complexity, solubil-
ity, and ionization issues. Furthermore, by selecting only
a small subset of peptides, the methodology is more sen-
sitive to post-translational modification (PTM). Methods
based on full-length protein expression also allow for a
more accurate quantification and amore robust statistical
assessment, while precipitation issues related to peptide
storage are systematically bypassed. It is generally agreed
that the spiking of the labeled standard should be intro-
duced as early as possible during the sample fractionation
steps to secure that both the standard and its endogenous
counterpart are subject to the same artifacts. Therefore,
sample losses or differential proteolytic treatments that
may affect downstream measurements are minimized.
4 Enrichment for TFs is crucial to permit
their detection and subsequently their
quantification
Within a eukaryotic cell, TFs tend to spend considerable
time in the nucleus where they act in conjunction with other
molecules to activate or repress the expression of their target
genes. That is why the vast majority of proteomic TF studies
focus on the nuclear fraction, even though several members
of this family of regulatory proteins are also located on the
nuclear envelope (e.g. nuclear receptors) or in the cytoplasm.
The nuclear environment is deemed very complex, consist-
ing of a large number of factors that are entangled within a
chromatin meshwork, which may hamper the full recovery
of relevant factors using conventional extraction procedures.
Due to the fact that TFs tend to be lower expressed than
other types of proteins, and considering the limited levels
of sensitivity permitted by MS-based approaches in detect-
ing low abundance molecules, several studies have opted for
approaches aimed at isolating and enriching for TFs using
specifically designed DNA motifs. Although the endogenous
context in which these TFs operate in vivo is now disrupted,
TFs can be retrieved in sufficient amounts by their affinity
to their respective consensus DNA sequences to allow DNA-
protein interaction studies and derive quantitative informa-
tion in the process. Although we have previously reviewed
techniques aimed at studying DNA-protein interactions in
greater extent [36], a few interesting novel methodologies
based on TF purification have recently been implemented
(e.g. [37, 38]). In this context, improvements in DNA pull
down-based affinity strategies have permitted to reliably iden-
tify and subsequently quantify consensus sequence-specific
protein interactors. Ding and colleagues [39] developed an
affinity reagent composed of synthetic DNA incorporating
concatenated tandem array of consensus TFREs (TF response
elements) termed catTFRe for a vast number of TF fami-
lies. This procedure was shown effective in enriching TFs
from cells in an in vitro context in a high throughput set-
ting. The authors reported the identification of as high as 400
TFs from a single cell line and 878 TFs from 11 cell types
in total. Their approach is also compatible with the quan-
tification of proteome-wide changes in DNA-binding profiles
of cellular TFs in response to specific stimuli or perturba-
tions by utilizing a label-free strategy. Along the same lines,
Hubner and co-workers [40] introduced a high throughput
compatible DNA-based system that takes advantage of on-
bead digestion for DNA pull-downs combined with label-free
as well as direct dimethyl labeling protein quantification ap-
proaches. Using this approach, the researchers were able to
isolate and quantify nearly 7000 nuclear proteins in K562 and
PBMC cells utilizing an external universal protein standard
mix. As such, their approach is intended to ease laboratory
procedures and increase the throughput of DNA-protein in-
teraction proteomics. A similar workflow based on on-bead
protein digestion of DNA pulldowns coupled to dimethyl la-
beling was implemented by Makowski and colleagues [41] to
explore variable TF binding at the human telomerase reverse
transcriptase promoter region. In contrast with the previ-
ous study however, the variable nature of TF binding upon
promoter mutations was elucidated by deriving relative mea-
surements.
Although affinity TF purification strategies have the advan-
tage of allowing the enrichment of selected TFs through the
use of their DNA consensus elements, such methods oper-
ate predominantly in an in vitro setting and are DNA-centric.
However, isolating regulatory proteins directly from their na-
tive environment is, as already indicated, not a trivial task.
Nevertheless, identifying and quantifying TFs in an endoge-
nous context would alleviate biases that are introduced when
employing synthetic molecular components. Cross-linking
methodologies have in this context become an interesting
option to enrich for transiently bound chromatin-associated
proteins. This is because chromatin enrichment methodolo-
gies can be easily coupled to various strategies aimed at iden-
tifying and quantifying chromatin bound proteins in general.
Recently, Kustatscher and colleagues [42] introduced such a
Chromatin Enrichment for Proteomics (ChEP) strategy. This
relatively straightforward biochemical approach based on in-
terphase chromatin enrichment enabled a comprehensive in-
vestigation of global chromatin composition and its changes
[43], as opposed to previously developed strategies that ei-
ther focus on specific chromatin loci or have more limited
specificity.
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Gel-based methodologies are also an interesting alterna-
tive to selectively enrich for TFs of interest. We have previ-
ously reported the development of a multiplexed MS-based
approach aimed at measuring selected TFs directly from cells
which utilizes SDS-PAGE to isolate TFs of interest accord-
ing to their molecular weight [11]. As only the fraction of the
gel containing the bands of the proteins of interest is con-
sidered, a significant increase in sensitivity can be achieved.
This in turn overcomes issues related to the high abundance
of specific nuclear components (e.g. histones) which in a
mass spectrometer can obscure signals of their less abundant
counterparts. This methodology has allowed us to enrich for
selected TFs and derive quantitative data along a process of
cellular differentiation [11].
In sum, what is currently clear is that without a proper
enrichment strategy, only the most abundant factors will be
detected, thus scratching only the surface of the cellular TF
proteome. Different methods are available to the researcher
that can aid in enriching for DNA-binding proteins. The
method that will ultimately be selected depends largely on
the scope of the study. Nevertheless, it is important to em-
phasize that it remains challenging to efficiently enrich or
extract chromatin-associated proteins under conditions that
are compatible with mass spectrometry, independent of the
chosen assay [44]. One important consequence is the elevated
risk for underestimating protein amounts when dealing with
TFs. Proteomic measurements are therefore best comple-
mented with other technologies to corroborate the generated
data [e.g. 11], and thus to possibly correct for the effects of a
suboptimal nuclear protein extraction.
5 Relative versus absolute quantification
in discovery-based studies
Relative quantification is achieved when comparing protein
amounts between at least two different samples (e.g. healthy
vs. disease, wild type vs. mutant) or conditions of the same
samples (e.g. perturbation or time-course analyses). These
applications therefore allow the capture of temporal changes
and comparison among proteomes in a straightforwardman-
ner, and have become in the past decade a gold standard
in proteomics. Although TFs do occasionally get caught in
the fishing net of large-scale proteomics studies, their de-
tectability with MS-based methods remains rather low. Even
with the most sensitive instrumentation available, discovery-
based comparative proteomics studies aimed at studying TF
dynamics have to be carefully designed and the methodology
needs to be tailored to its scope. For example, using a five-
plexed SILAC-based MS approach, Molina and co-workers
[45] identified 882 nuclear and secreted proteins (but only
a few TFs) at five different time-points of adipogenesis. For
about half of them, relative quantitative measurements were
obtained. In addition, Pascual and colleagues [46] utilized a
combination of mass spectrometry state-of-the-art methods
based on the use of organelle purification followed by gel
and label-free approaches that were coupled to novel bioin-
formatics methods. Using this approach, these researchers
studied variations in the nuclear proteome resulting fromUV
time-dependent irradiation in Pinus radiata enabling them to
identify 33 TFs among 388 nuclear proteins related to stress
responsive mechanisms. This in turn allowed them to char-
acterize these proteins as potential biomarker candidates for
breeding programs destined to improve UV resistance, and
thus productivity in forest species. Their effort is an elegant
example of how a proteomics-centered integrative strategy
can be used to gain a deeper understanding of nuclear pro-
tein dynamics. Remaining in plants, Huo and co-workers [47]
utilized two dimensional difference gel electrophoresis (2D-
DIGE) coupled to MS to study the early regulatory events
that orchestrate the cold response in rice. The researchers
identified gel spots that reflected altered protein expression
levels upon cold treatment. Only five minutes after cold expo-
sure, the abundance levels of 26 proteins were significantly
altered. Additional evidence suggested that one of these 26
proteins, OsPLD1, has a role in early cold-regulated cellu-
lar responses, consistent with its earlier established function
in transducing cold signaling in rice. Thus, a combination
of gel-based as well as LC-MS/MS approaches allowed the
identification of a key cold stress-response protein.
Although the vast majority of studies aiming to quantita-
tively characterize TF amounts are comparative in nature, the
necessity for researchers to obtain accurate protein measure-
ments has spurred an increasing interest to develop method-
ologies aimed at quantifying fractions of the proteome in
absolute amounts. Despite such efforts, absolute quantifica-
tion remains rather challenging from a technical perspective
compared to relative (comparative) quantification. Neverthe-
less, recent improvements in sensitivity and throughput have
allowed for a more routine implementation of absolute quan-
tification methodologies. An elegant implementation of the
absolute SILAC methodology, SILAC-PrEST [48], used a sol-
ubilization tag to quantify in absolute terms the amount of
recombinant PrESTs (Protein Epitope Signature Tags) pro-
duced in vivo to quantify 40 selected proteins in HeLa cells.
One of the benefits of the utilized ABP (Albumin Binding
Protein) solubilization tag is that most of its tryptic peptides
can be used for quantification, increasing the overall robust-
ness of the approach. Additionally, the two steps of quantifi-
cation of the recombinant PrESTs and of their endogenous
counterparts were collapsed in one single experiment, sim-
plifying the workflow as a whole. Using this approach, Zeiler
and co-workers [48] were able to accurately quantify TFs such
as proto-oncogene c-Fos at approximately 5–6000 copies per
cell, and Zfp828 at approximately 70–75 000 copies per cell.
6 Towards the use of targeted proteomic
approaches: SRM/MRM
Novel applications in quantitative proteomics and advances
in MS technology development are now permitting to
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accurately measure protein amounts in a given mixture in
absolute terms. One technique in particular, named Selected
ReactionMonitoring (SRM), also known asMultiple Reaction
Monitoring (MRM), has become a benchmark in targeted pro-
teomics approaches, since it allows the detection and quantifi-
cation of predetermined sets of proteins, based on selected
peptide fragmentation reactions, in complex samples with
previously never achieved sensitivity and specificity. This in
turn allows for a more in-depth analysis of the proteome, par-
ticularly those proteins that are expressed at levels that tend to
obscure detection with canonical MS approaches. The most
important aspect of SRM, when it comes to quantification, is
the consistency and the uniqueness of the selected peptides.
Only peptides that uniquely identify a protein of interest, and
that are consistently detected in different MS runs should be
utilized; such peptides are termed “proteotypic.” Moreover,
when selecting such peptides, one has to be careful in select-
ing the highest responding peptides for each protein of inter-
est. There is no gold standard for the identification of such pep-
tides. Nevertheless, several bioinformatic tools that guide the
user in the selection of proteotypic peptide candidates based
on a set of physicochemical properties are currently available
[49–52]. The best responding peptides are usually selected
for validation. In recent years, SRM coupled to stable-isotope
labeling techniques has been adopted for estimating cellu-
lar protein levels in large-scale proteomic analyses. Most of
such efforts were aimed at quantifying a large fraction of the
proteome, covering the largest possible dynamic range [53].
As the complexity of the model system studied increases,
mainly due to technical limitations, venturing in the lower
levels of the expression range where many TFs reside quickly
becomes very challenging. In this regard, few large scale pro-
teomics studies have attempted to quantify TFs identified in
a discovery-based mode utilizing a targeted approach. An ex-
ample of such a strategy is the study of Beck and colleagues
[54], who estimated that the least abundant TFs detected in
their study using a human cell line were present at less than
500 copies per cell. TF-focused efforts would therefore be
greatly aided by the availability of TF peptide-specific infor-
mation since such data would not only enable improvements
in protein identification speed and accuracy, but also amelio-
rate cross-comparisons of quantitative proteomics data and
allow for amore efficient development of targeted proteomics
assays. However, to date, no comprehensive TF proteotypic
peptide database has been developed. Nevertheless, an inter-
esting advance was introduced by Stergachis and colleagues
[9]. These researchers developed a high-throughput, cost-
effective methodology for the discovery of optimal precursor-
and fragment- ions that can be utilized in targeted proteomics
assays based on the use of in vitro-synthesized full-length
proteins. Absolute quantification of in vitro-expressed TFs is
accomplished via two GST (Glutathione-S-transferase) signa-
ture peptides. Using their approach, optimal transitions for
96 human TFs were experimentally derived, after which the
expression and enrichment of 44 of these TFs was empirically
tested and verified. The utility of the derived ion transitions
to quantify endogenous TFs was tested by measuring the
relative abundance of six candidates between four human
cell lines. To also address this evident lack of TF peptide
data in public repositories, we generated a relatively large, ex-
perimentally derived TF proteotypic peptide spectral library
dataset based on in vitro-expressed TFs using a high-yield
Gateway-compatible protein expression system [55]. Our li-
brary currently contains peptide information for 89 TFs and
this number is set to increase in the near future. Such an
effort enabled us to utilize TF-specific peptide information
to develop a sensitive SRM-based mass spectrometry assay to
quantify TFs in absolute terms.Using this assay, wewere able
to simultaneously determine the copy numbers of ten pre-
determined TFs. We subsequently applied the methodology
to profile the absolute levels of pro-adipogenic TFs, including
the master regulators PPAR and RXR, over the course of
terminal differentiation ofmouse 3T3-L1 pre-adipocytes. Our
analyses revealed that the individual abundance of TFs dif-
fers dramatically (from250 to>300 000 copies per nucleus)
and that their dynamic range during differentiation can vary
up to fivefold. Using these data, we were able to formulate a
highly predictive DNA bindingmodel for PPAR. Thismodel
was not only based on TF copy number, but also on binding
affinity data and local chromatin state, demonstrating the
feasibility of studying and even predicting the DNA binding
behavior of TFs using these parameters across a wide range
of biological processes. A comparable approach was used by
Narumi and co-workers, who devised a methodology termed
MS-QBiC (MS-based Quantification By isotope-labeled Cell-
free products), that makes use of appositely designed internal
standards for protein quantification by using a reconstituted
cell-free protein system [56]. Such an SRM-based workflow al-
lowed the researchers to monitor the abundance fluctuations
of core circadian rhythm proteins (including TFs).
As targeted methodologies seemed to have hit the mark
with respect to the detection and quantification of DNA-
binding proteins, much effort is being devoted to further
optimize these SRM-based protocols. For example, Zhao and
colleagues [57] introduced an interesting proof of concept
study in which they described the important steps in building
a comprehensive SRM-based workflow to quantify relatively
low abundant molecules using the innate immune response
as a model system and the TF interferon response factor
(IRF)-3 as target. Kim and colleagues [58] implemented a
comparable SRM-based methodology that was optimized for
quantifying TFs in lung cancer related cell lines without de-
pletion or fractionation of the cell lysates (28 TFs in eight cell
lines). These researchersmanaged to for example quantify the
TF STAT3 at less than 20 amol/g of proteins, demonstrating
high detection sensitivity. To better understand the regulated
mechanisms underlyingmammalian cellular differentiation,
Ahrends and colleagues [59] utilized an integrated approach
based on a combination of methods, including SRM. Specif-
ically, a panel of selected nuclear proteins (including TFs)
was selected for quantitative analyses upon chemical and ge-
netic perturbations to obtain comparative, quantitative data
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that enabled the development of models to study feedback
loops in adipogenic cell fate decisions. In follow-up work,
the abundance of 42 nuclear proteins in subcutaneous and
visceral white adipose tissue was compared to provide novel
insights into functional differences between different types
of adipocytes in healthy and disease tissues [60].
These examples illustrate how targeted proteomics ap-
proaches are proving to be rather versatile and robust, as they
can be easily coupled to various TF enrichment procedures
that afford the necessary sensitivity to detect low abundant
molecules while providing an unprecedented level of repro-
ducibility. Mirzaei and colleagues [61] further demonstrated
the utility of targeted proteomics methodologies by imple-
menting SRM-based protein profiling aimed at systematically
detecting a large fraction of the TF proteome with high repro-
ducibility and measurement accuracy in unfractionated nu-
clear extracts. Their strategy based on the enrichment of spe-
cific TFs using a concatenated tandem array of TF response
elements, has permitted the measurement of 464 proteins
with known or suspected roles in transcriptional regulation at
RNA polymerase II transcribed promoters in Saccharomyces
cerevisiae. The researchers further validated the utility of their
strategy by demonstrating that two of the SRM identified TFs,
Mot3 and Azf1, were required for proper flocculation protein
FLO11 expression.
In conclusion, SRM appears to live up to its expecta-
tions. Its high degree of sensitivity and specificity, combined
with the reproducibility and ease of implementation of the
methodology even in novice proteomics laboratories has pro-
pelled this technique to the forefront ofMS-based quantitative
proteomics technologies.
7 Concluding remarks: digging deeper in
the TF proteome—The future quest for
TF detection and quantification
In this review, we presented a broad picture of methodolo-
gies and recent studies aimed at deriving measurements of
this particular family of DNA-binding proteins for compara-
tive purposes, or at obtaining absolute amounts (Table 1). TF
studies are also becoming rather comprehensive, for exam-
ple, by including other regulatory molecules of importance,
and by moving beyond a static picture, consistent with the
ever-changing and adapting nature of biological processes.
However, while becoming more frequent, there is still a gen-
eral lack of quantitative TF information, which stands in stark
contrast to their well-established biological importance. Pio-
neeringworkwas first accomplished in bacteria and lower eu-
karyotes before TF copy numbers per cell were measured in
mouse and human. However, although TFs are being fished
out in the context of large-scale efforts aimed at determining
copy numbers for a large fraction of an organism’s entire
proteome, still too few comprehensive studies have so far fo-
cused on quantitatively monitoring the dynamic behavior of
TFs in specific biological processes. One underlying reason
is the relatively low expression of TFs, at least compared to
other protein types. This presents a great challenge in terms
of obtaining the necessary sensitivity to identify and quantify
TFs. Moreover, since the copy number of TFs tends to span
several orders of magnitude in cells, it is of primary impor-
tance that high quantitative accuracy ismaintained across this
dynamic expression range. However, stochastic, systematic,
and scaling errors can contribute to biased measurements,
which can introduce important errors as outlined in Li et al.
[10]. Although there is no clear consensus onwhat technology
should be utilized to validate quantitative mass spectrome-
try data (and to what extent mass spectrometry data should
be validated, if at all (e.g. [62]), we urge researchers to criti-
cally approach quantitative mass spec data, and if possible, to
confirm these data with orthogonal technologies (at least for
a subset of protein candidates). Several recent studies have
implemented this strategy involving for example immuno-
based methods to increase data robustness and accuracy (e.g.
[11,63–65]). Thus, using such a validation strategy, along with
selecting good quantification standards [66], it will be easier
to control for different sources of errors.
To conclude, it is well understood that it will be impossi-
ble to fully describe biological processes without unraveling
the regulatory mechanisms that orchestrate these same pro-
cesses. Such a description will require the type of accurate
quantitative protein data that MS-based approaches are in-
creasingly able to provide. This explains the significant efforts
that are being invested in advancing MS-based technologies,
now enabling analytical capabilities that only a decade ago
seemed unreachable. Exciting research lies therefore ahead.
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